Neuroscience

Neuroscience Research

Overview

At the AdventHealth Research Institute, we are passionate about helping people with neurological disorders live better lives. That's why we are dedicated to finding new ways to prevent, treat and, ultimately, cure neurological disorders that affect millions of people around the world. 

Using the latest in pharmaceutics, medical devices and bedside techniques to collect and analyze data, we’re able to understand how neurologic conditions affect the brain, leading to better preventative and treatment options. Our multidisciplinary team of neuroscience physicians, nurses and researchers are on the cutting-edge with research studies in a wide range of modalities, including physician-initiated trials. Join us in our mission to create a brighter future for brain health. 

Join a Neuro Research Study 

We work closely with our neuroscience clinical teams to uncover ways in which we can enhance our quality of care to make it affordable, connected and exceptional to the community that we serve. 

You could be part of the next breakthrough in Neuroscience research. As a research study participant, you could: 

  • Access new and innovative therapies that may not be available otherwise 

  • Help advance medical knowledge and benefit future generations 

  • Receive expert care and support from our experienced and compassionate team 

  • Earn compensation for your time and travel expenses 

By joining a research study, you are helping us unlock the mysteries of the brain, leading to better treatments, care and prevention of neurologic disorders. 

Contact Information

Neuroscience Institute Research Department

Areas of Focus

  • Alzheimer's Disease and Dementia 

  • Brain Tumors 

  • Epilepsy 

  • Headache and Migraine 

  • Movement Disorders 

  • Multiple Sclerosis and Neuroimmunology 

  • Neurology 

  • Neuromuscular Medicine 

  • Neurovascular Disorders 

  • Stroke 

Join a Research Study

Featured Clinical Trials

NCT05766813

“A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients with Motor Fluctuations due to Parkinson’s Disease”

Icon for trial | ITI-214-202 “A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients with Motor Fluctuations due to Parkinson’s Disease”

This study is currently enrolling.

The purpose of this clinical research study is to look at an investigational study drug called lenrispodun. The study will investigate if lenrispodun can help to increase the time of good control of movement symptoms, that is, ...

NCT05399888

Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia

Icon for trial | 247AD201 Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer&rsqu

This study is currently enrolling.

Alzheimer’s Disease (AD): The purpose of this study is to look at whether BIIB080 (the study drug) can help people with Alzheimer’s Disease (AD), how safe it is, and how the body handles taking it (known as tolerability). Parti ...

Meet the Team

Anwar Ahmed

Anwar Ahmed, MD

Medical Director of Neurology

Full Bio
Kirk Erickson, PhD

Kirk Erickson, PhD

Chair of Neuroscience Institute

Full Bio
Nivedita Jerath

Nivedita Jerath, MD,MS

Neurologist

Full Bio
Mitesh Lotia

Mitesh Lotia, MD

Medical Director and Neurologist

Full Bio

Our Capabilities

The Neuroscience Institute treats more neurological patients than any other hospital in the United States. This assures our patients that they’re in experienced hands. We offer skilled physicians and specially trained health care professionals. We invest in state-of-the-art technology, which means our patients are afforded the latest, most advanced treatment options and techniques available, including:

  • Endoscopic Endonasal Skull Base Surgery
  • Brain Port Surgery
  • Endoscopic Microvascular Decompression
  • Gamma Knife® Perfexion™
  • MRI-guided Laser Interstitial Thermal Therapy
  • Interventional Neuroradiology (INR)

This technology is considered the gold standard in non-invasive brain surgery. Treating complex conditions with tiny incisions or no incisions, this technique reduces pain, scarring and recovery time. By delivering a single dose of radiation that accurately targets the tumor, the patient doesn't require multiple treatments. Gamma Knife Radiosurgery is a non-invasive brain surgery procedure, and despite its name, does not use blades or incisions. Instead, it targets and destroys diseased brain tissue with precisely focused radiation, while leaving surrounding healthy tissue unharmed. In fact, this treatment technology allows physicians to treat brain tumors, lesions, vascular malformations and functional disorders that were once considered inoperable.

AdventHealth is the only health care provider in Central Florida using this robotic-assisted, state-of-the-art technology. The Gamma Knife Center at AdventHealth Orlando includes a multidisciplinary team of medical experts from neurosurgery and radiation oncology. We have one of the largest and most experienced teams in the country, and utilize the Leksell Gamma Knife® Perfexion™—one of the most technologically advanced non-invasive brain surgery techniques available today.